First-in-class thyrotropin-releasing hormone (TRH)-based compound binds to a pharmacologically distinct TRH receptor subtype in human brain and is effective in neurodegenerative models

Highlights

  • First-in-class TRH-based compound JAK4D detects new receptor subtype in human brain.
  • 388 more words